How do you approach ADT in a post-prostatectomy patient who had higher Gleason score on biopsy but a lower Gleason score on final pathology?

For example, if patient had Gleason 4+5 on biopsy but Gleason 4+3 with Tertiary Grade 5 on final pathology? Would you consider intensifying their hormone therapy with longer duration or addition of Abiraterone?

Answer from: Radiation Oncologist at Academic Institution

I would only base my decision on the pathology of the final prostatectomy specimen, and ignore the prior biopsies.

Please select the option that best describes you:

How do you approach ADT in a post-prostatectomy patient who had higher Gleason score on biopsy but a lower Gleason score on final pathology?

Related Questions